Click on one of these terms to refine your search
1 to 10 of 24 literature results
-
Pleiotropic effects of fenofibrate.
Fenofibrate represents the most commonly used fibric acid derivative. The drug exerts its metabolic effects by modulating the expression of several ge…
Authors: V Tsimihodimos, E Liberopoulos, M Elisaf
Source: Current pharmaceutical design. 2009
View Full Text -
Risk factors for first-ever acute ischemic non-embolic stroke in elderly individuals.
BACKGROUND: Stroke is a leading cause of mortality and subsequent serious long-term physical and mental disability among survivors. In the elderly, is…
Authors: Haralampos J Milionis, Evangelos Liberopoulos, John Goudevenos, Eleni T Bairaktari, Konstantinos Seferiadis, Moses S Elisaf
Source: International journal of cardiology. 2005 Mar 18
View Full Text -
Successful treatment of human immunodeficiency virus-related Castleman's disease: a case report and literature review.
Multicentric Castleman's disease is increasingly recognized as an aggressive illness with a rapidly fatal outcome in human immunodeficiency virus (HIV…
Authors: Evagelos Liberopoulos, Christos Tolis, Mary Bai, Stavros Efremidis, Nikolaos Pavlidis, Moses Elisaf
Source: Oncology. 2003
View Full Text -
Aminoglycoside-induced reversible tubular dysfunction.
Nonoliguric renal insufficiency is a well-known nephrotoxic consequence of aminoglycosides, although reversible tubular damage in the absence of any c…
Authors: George Alexandridis, Evagelos Liberopoulos, Moses Elisaf
Source: Pharmacology. 2003 Mar
View Full Text -
The effects of the addition of micronised fenofibrate on uric acid metabolism in patients receiving indapamide.
OBJECTIVE: Hyperuricaemia is associated with indapamide administration. In contrast, micronised fenofibrate can significantly decrease serum uric acid…
Authors: Apostolos Achimastos, Evagelos Liberopoulos, Spyros Nikas, Eleni Bairaktari, George Miltiadous, Vasilios Tsimihodimos, Moses Elisaf
Source: Current medical research and opinion. 2002
View Full Text -
Apolipoprotein E polymorphism in northwestern Greece: frequency and effect on lipid parameters.
Apolipoprotein (apo) E gene polymorphism and its effect on serum lipid parameters were examined in a Greek population originating from northwestern Gr…
Authors: Evagelos Liberopoulos, George Miltiadous, Marilena Hatzivassiliou, Navsika Ayrton, Eleni Bairaktari, Marios Cariolou, Moses Elisaf
Source: Annals of clinical and laboratory science. 2004
View Full Text -
A tumor lysis-like syndrome during therapy of visceral leishmaniasis.
Reported herein for the first time in the literature is the case of a 41-yr-old woman who developed a tumor lysis-like syndrome, consisting of hyperka…
Authors: Evagelos Liberopoulos, George Alexandridis, Moses Elisaf
Source: Annals of clinical and laboratory science. 2002
View Full Text -
Are the effects of tamoxifen on the serum lipid profile modified by apolipoprotein E phenotypes?
BACKGROUND: Tamoxifen has favorable effects on the serum lipid profile. It has been suggested that the apolipoprotein (Apo) E phenotype can influence …
Authors: Evagellos Liberopoulos, Sonia-Athena Karabina, Alexandros Tselepis, Eleni Bairaktari, Costas Nicolaides, Nikolaos Pavlidis, Moses Elisaf
Source: Oncology. 2002
View Full Text -
Severe hypocholesterolemia with reduced serum lipoprotein(a) in a patient with visceral leishmaniasis.
We report the case of a 36-yr-old man with visceral leishmaniasis who presented with marked hypocholesterolemia, mild hypertriglyceridemia, severely d…
Authors: Evagellos Liberopoulos, George Alexandridis, Eleni Bairaktari, Moses Elisaf
Source: Annals of clinical and laboratory science. 2002
View Full Text -
Apolipoprotein E and renal disease.
Apolipoprotein E (ApoE) is a major constituent of plasma lipoproteins with many biological actions of great significance. Beyond the known influence o…
Authors: Evagelos Liberopoulos, Kostas Siamopoulos, Moses Elisaf
Source: American journal of kidney diseases : the official journal of the National Kidney Foundation. 2004 Feb
View Full Text
